FDA Import Refusal 1FX-6179109-1/20002/1 — DAEWOONG PHARM CO LTD
The FDA refused shipment 1FX-6179109-1/20002/1 from DAEWOONG PHARM CO LTD (South Korea) on Aug 25, 2026. The refused product falls under Drugs and Biologics — ONABOTULINUMTOXINA. Cited charges: 9999979,9999982 This firm has 3 other import refusals on record.
Refusal details
- Date
- Aug 25, 2026
- Country
- South Korea
- Product Category
- Drugs and Biologics
- Product Code
- 58PDY05 ONABOTULINUMTOXINA
- Charges
- 9999979,9999982